What did the FDA do about tanning bed rules?

FDA backed away from stricter tanning bed rules

U.S. health regulators moved to loosen a proposed crackdown on indoor tanning after the effort faced political and public pushback. Coverage describes the FDA withdrawing a proposal that would have barred Americans under 18 from using tanning beds.

The sequence matters for consumer safety because indoor tanning is linked to skin cancer risk, and stricter age limits are typically aimed at reducing exposure among adolescents and teens.

Reports also said health officials backed away from heavier regulation with support associated with Health Secretary Robert F. Kennedy Jr., even as medical groups warned that teens face disproportionate harm from UV exposure.

Why it matters: tanning bed rules can affect how quickly patterns of use shift in the populations most at risk for skin cancer later in life. A reversal also affects how regulators will approach future proposals—whether they return to age-based restrictions, pursue different regulatory levers, or focus on enforcement and public health messaging instead.

The key outcome in the coverage is straightforward: regulators withdrew the proposed rule banning tanning bed use by people under 18, rather than moving ahead with it.